P021 A pragmatic randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy for early breast cancer (REaCT-CHRONO Study). (April 2023) - Savard, M.-F.; Ibrahim, M.; Pond, G.R.; Saunders, D.; Vandermeer, L.; Fallowfield, L.J.; Ng, T.L.; Awan, A.A.; Sehdev, S.; Beltran-Bless, A.A.; Clemons, M.